Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

LALPATHLAB is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.

Financial Ratios:

currentRatio 3.508000
forwardPE 38.748493
debtToEquity 6.441000
earningsGrowth 0.163000
revenueGrowth 0.107000
grossMargins 0.582570
operatingMargins 0.251300
trailingEps 32.070000
forwardEps 35.521380

LALPATHLAB's current ratio of 3.508 highlights the company's solid liquidity, indicating that it can easily service its short-term debt. LALPATHLAB's ample cash reserves and current assets ensure that the company is well-positioned to meet its immediate financial liabilities.
Positive earnings and revenue growth for LALPATHLAB point to expected business expansion. The company is projected to continue growing its operations, as increasing profits and sales highlight a strong trajectory for further growth in the future.
Positive gross and operating margins for Dr. Lal PathLabs Limited suggest that the company is operating profitably. These margins highlight Dr. Lal PathLabs Limited's efficiency in managing costs while maintaining healthy revenue streams, contributing to its overall financial strength.
LALPATHLAB's forward EPS surpassing its trailing EPS signals projected growth in profitability, with the company expected to perform better this year. This forecast suggests that LALPATHLAB's earnings will improve compared to the previous financial year, highlighting optimism in its financial outlook.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

Over time, LALPATHLAB's price projections have consistently been revised lower. This downward shift suggests analysts are becoming more cautious about the company's future, possibly due to emerging risks or challenges.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


Recent trading of Dr. Lal PathLabs Limited stock saw 43 sales, with market price at 3000.7209273937137 per share.LALPATHLAB had 1 buy transactions, with market price of 3308.5.Insider transactions show no strong upward or downward movement, offering little insight into the company's future performance or strategic direction.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Recent analysis shows a strong buy bias for LALPATHLAB, encouraging investors to view it as a solid investment option. The positive sentiment surrounding LALPATHLAB suggests it could be an attractive place to allocate funds, motivating potential investors to consider the stock as a valuable part of their portfolio.